MFDS — authorised 13 March 2013
- Marketing authorisation holder: NAVIDEA BIOPHARMS
- Status: likely_approved
🇰🇷 Lymphoseek Kit in South Korea
MFDS authorised Lymphoseek Kit on 13 March 2013
Marketing authorisation
Lymphoseek Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Lymphoseek Kit approved in South Korea?
Yes. MFDS authorised it on 13 March 2013.
Who is the marketing authorisation holder for Lymphoseek Kit in South Korea?
NAVIDEA BIOPHARMS holds the South Korean marketing authorisation.